Opioids for chronic noncancer pain: A position paper of the American Academy of Neurology

Neurology

Volumn 84, Issue 14, 2015, Pages 1503-1505

  Katz, Jeffrey A ^a   Swerdloff, Marc A ^a   Brass, Steven D ^a   Argoff, Charles E ^a   Markman, John ^a   Backonja, Misha ^a   Katz, Nathaniel ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; GABAPENTIN; METHADONE; OPIATE; PREGABALIN; NARCOTIC ANALGESIC AGENT;

ANALGESIA; CENTRAL SLEEP APNEA SYNDROME; CHRONIC PAIN; DRUG INDUSTRY; EDITORIAL; EVIDENCE BASED PRACTICE; HARM REDUCTION; HEALTH CARE ORGANIZATION; HUMAN; HYPOVENTILATION; HYPOXEMIA; MORBIDITY; MORTALITY; NEUROLOGIST; NEUROLOGY; OPIATE ADDICTION; PHYSICIAN; PRIORITY JOURNAL; RISK REDUCTION; SCREENING; SLEEP DISORDERED BREATHING; VITAL SIGN; ANIMAL;

ANALGESICS, OPIOID; ANIMALS; CHRONIC PAIN; HUMANS; PAIN MANAGEMENT;

EID: 84926656752     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001485     Document Type: Editorial

References (17)

1. Franklin GM. Opioids for chronic noncancer pain: a position paper of the American Academy of Neurology. Neurology 2014;83:1277-1284
2. Fenton JJ, Jerant AF, Bertakis KD, et al. The cost of satisfaction: a national study of patient satisfaction, health care utilization, expenditures, and mortality. Arch Intern Med 2012;172:405-411
3. Farney RJ, Walker JM, Cloward TV, Rhondeau S. Sleepdisordered breathing associated with long-term opioid therapy. Chest 2003;123:632-639
4. Sharkey KM, Kurth ME, Anderson BJ, Corso RP, Millman RP, Stein MD. Obstructive sleep apnea is more common than central sleep apnea in methadone maintenance patients with subjective sleep complaints. Drug Alcohol Depend 2010;108:77-83
5. Teichtahl H, Promdromidis A, Miller B, Cherry G, Kronborg I. Sleep-disordered breathing in stable methadone programme patients: a pilot program. Addiction 2001;96:395-403
6. Wallace M, Thipphawong J. Open-label study on the long-term efficacy, safety and impact on quality of life of OROS hydromorphone ER in patients with chronic low back pain. Pain Med 2010;11:1477-1488
7. McIlwain H, Ahdieh H. Safety, tolerability, and effectiveness of oxymorphone extended release for moderate to severe osteoarthritis pain: a one-year study. Am J Ther 2005;12:106-112
8. Portenoy RK, Farrar JT, Backonja MM. Long-term use of controlled-release oxycodone for non-cancer pain: results of a 3-year registry study. Clin J Pain 2007;23: 287-299
9. Sandner-Kiesling A, Leyendecker P, Hopp M, et al. Longterm efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of noncancer chronic pain. Int J Clin Pract 2010;64:763-774
10. Meier B. In guilty plea, oxycontin maker to pay $600 million. New York Times May 10, 2007. Available at: http://www.nytimes.com/2007/05/10/business/11drug-web. html?-r51&. Accessed January 19, 2015
11. Fauber J. UW a force in pain growth: research group receiving millions from pharmaceutical firms helped liberalize use of opioids. Milwaukee Journal Sentinel April 2, 2011. Available at: http://www.jsonline.com/watchdog/watchdogreports/119130114.html. Accessed January 19, 2015
12. Ornstein C, Weber T. Senate panel investigates drug companies' ties to pain groups. Washington Post May 8, 2012. Available at: http://www.washingtonpost.com/national/health-science/senate-panel- investigates-drug-companies-tiesto-pain- groups/2012/05/08/gIQA2X4qBU-story.html?. hpid5z4. Accessed January 19, 2015
13. Mularski RA, White-Chu F, Overbay D, et al. Measuring pain as the 5th vital sign does not improve quality of pain management. J Gen Intern Med 2006;21:607-612
14. Gronseth GS, Woodroffe LM, Getchius TSD. Clinical practice guideline process manual. Am Acad Neurol 2011. Available at: http://tools.aan.com/globals/axon/assets/9023.pdf. Accessed January 19, 2015
15. Reuben DB, Alvanzo AAH, Ashikaga T, et al. National Institutes of Health Pathways to Prevention workshop: the role of opioids in the treatment of chronic pain. Ann Intern Med 2015;162:295-300
16. Ballantyne JC, Stannard C. New addiction criteria: diagnostic challenges persist in treating pain with opioids: International Association for the Study of Pain. Pain Clin Updates 2013;21: 1-7. Available at: http://iasp.files.cms-plus.com/FileDownloads/PCU-21-5-web.pdf. Accessed January 19, 2015
17. Dworkin RH, Turk DC, Wyrwich KW, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 2008;9:105-121